ALPS Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.03M | Sell |
50,414
-3,697
| -7% | -$518K | 0.03% | 211 |
|
|
2025
Q4 | $6.64M | Buy |
54,111
+198
| +0.4% | +$24.1K | 0.04% | 217 |
|
|
2025
Q3 | $5.98M | Buy |
53,913
+34,083
| +172% | +$3.87M | 0.03% | 224 |
|
|
2025
Q2 | $2.2M | Buy |
19,830
+2,234
| +13% | +$238K | 0.01% | 354 |
|
|
2025
Q1 | $1.97M | Buy |
17,596
+190
| +1% | +$19.6K | 0.01% | 352 |
|
|
2024
Q4 | $1.61M | Sell |
17,406
-291,007
| -94% | -$26.2M | 0.01% | 375 |
|
|
2024
Q3 | $25.9M | Sell |
308,413
-84,455
| -21% | -$6.44M | 0.17% | 69 |
|
|
2024
Q2 | $27M | Buy |
392,868
+38,400
| +11% | +$2.56M | 0.19% | 58 |
|
|
2024
Q1 | $26M | Buy |
354,468
+24,189
| +7% | +$1.86M | 0.18% | 63 |
|
|
2023
Q4 | $26.8M | Sell |
330,279
-18,412
| -5% | -$1.43M | 0.21% | 58 |
|
|
2023
Q3 | $26.1M | Buy |
348,691
+10,670
| +3% | +$821K | 0.22% | 51 |
|
|
2023
Q2 | $26.1M | Sell |
338,021
-10,747
| -3% | -$857K | 0.23% | 66 |
|
|
2023
Q1 | $28.9M | Buy |
348,768
+22,189
| +7% | +$1.84M | 0.26% | 49 |
|
|
2022
Q4 | $28M | Sell |
326,579
-93,658
| -22% | -$7.42M | 0.25% | 52 |
|
|
2022
Q3 | $25.9M | Sell |
420,237
-110,237
| -21% | -$6.95M | 0.25% | 59 |
|
|
2022
Q2 | $32.8M | Buy |
530,474
+113,539
| +27% | +$7.03M | 0.32% | 41 |
|
|
2022
Q1 | $24.8M | Buy |
416,935
+80,853
| +24% | +$5.17M | 0.27% | 69 |
|
|
2021
Q4 | $24.4M | Sell |
336,082
-444
| -0.1% | -$30.6K | 0.27% | 62 |
|
|
2021
Q3 | $23.5M | Sell |
336,526
-28,825
| -8% | -$2.03M | 0.23% | 74 |
|
|
2021
Q2 | $25.2M | Sell |
365,351
-9,757
| -3% | -$652K | 0.22% | 69 |
|
|
2021
Q1 | $24.2M | Buy |
375,108
+36,155
| +11% | +$2.33M | 0.24% | 73 |
|
|
2020
Q4 | $19.7M | Buy |
338,953
+59,664
| +21% | +$3.6M | 0.22% | 102 |
|
|
2020
Q3 | $17.6M | Buy |
279,289
+9,119
| +3% | +$632K | 0.26% | 87 |
|
|
2020
Q2 | $20.8M | Sell |
270,170
-40,070
| -13% | -$3.07M | 0.28% | 56 |
|
|
2020
Q1 | $23.2M | Sell |
310,240
-233,564
| -43% | -$16.1M | 0.36% | 46 |
|
|
2019
Q4 | $35.3M | Buy |
543,804
+6,135
| +1% | +$400K | 0.28% | 68 |
|
|
2019
Q3 | $34.1M | Buy |
537,669
+3,416
| +0.6% | +$223K | 0.27% | 71 |
|
|
2019
Q2 | $36.1M | Sell |
534,253
-60,185
| -10% | -$3.96M | 0.27% | 78 |
|
|
2019
Q1 | $38.6M | Sell |
594,438
-25,712
| -4% | -$1.71M | 0.27% | 71 |
|
|
2018
Q4 | $38.8M | Sell |
620,150
-47,101
| -7% | -$3.29M | 0.3% | 56 |
|
|
2018
Q3 | $51.5M | Sell |
667,251
-25,839
| -4% | -$1.95M | 0.34% | 48 |
|
|
2018
Q2 | $49.1M | Buy |
693,090
+53,152
| +8% | +$3.75M | 0.32% | 57 |
|
|
2018
Q1 | $48.2M | Sell |
639,938
-32,101
| -5% | -$2.55M | 0.38% | 51 |
|
|
2017
Q4 | $48.1M | Buy |
672,039
+646,350
| +2,516% | +$49.1M | 0.33% | 64 |
|
|
2017
Q3 | $2.08M | Buy |
25,689
+1,949
| +8% | +$149K | 0.01% | 184 |
|
|
2017
Q2 | $1.68M | Buy |
23,740
+3,481
| +17% | +$232K | 0.01% | 192 |
|
|
2017
Q1 | $1.38M | Buy |
20,259
+10,761
| +113% | +$757K | 0.01% | 194 |
|
|
2016
Q4 | $680K | Buy |
9,498
+1,353
| +17% | +$101K | 0.01% | 247 |
|
|
2016
Q3 | $644K | Buy |
8,145
+713
| +10% | +$57.9K | 0.01% | 245 |
|
|
2016
Q2 | $620K | Buy |
7,432
+2,661
| +56% | +$236K | 0.01% | 226 |
|
|
2016
Q1 | $438K | Buy |
4,771
+369
| +8% | +$33.3K | ﹤0.01% | 436 |
|
|
2015
Q4 | $445K | Sell |
4,402
-100
| -2% | -$10.4K | ﹤0.01% | 554 |
|
|
2015
Q3 | $4.42K | Sell |
4,502
-755
| -14% | -$83.9K | ﹤0.01% | 595 |
|
|
2015
Q2 | $615K | Buy |
5,257
+82
| +2% | +$8.96K | 0.01% | 282 |
|
|
2015
Q1 | $508K | Buy |
5,175
+140
| +3% | +$14.2K | ﹤0.01% | 554 |
|
|
2014
Q4 | $475K | Sell |
5,035
-682
| -12% | -$70.5K | ﹤0.01% | 490 |
|
|
2014
Q3 | $609K | Sell |
5,717
-2,150
| -27% | -$211K | ﹤0.01% | 247 |
|
|
2014
Q2 | $652K | Buy |
7,867
+200
| +3% | +$15.6K | 0.01% | 275 |
|
|
2014
Q1 | $543K | Sell |
7,667
-23
| -0.3% | -$1.8K | 0.01% | 521 |
|
|
2013
Q4 | $620K | Buy |
7,690
+3,710
| +93% | +$258K | 0.01% | 194 |
|
|
2013
Q3 | $250K | Buy |
+3,980
| New | +$238K | ﹤0.01% | 424 |
|
Other funds holding GILD
VCM
VPM
ALPS Advisors's GILD Position: Q1 2026 in Review
ALPS Advisors reduced its Gilead Sciences (GILD) stake by 6.8% in Q1 2026, selling an estimated $518K and leaving 50,414 shares worth $7.03M. The position accounts for 0.03% of the portfolio, ranked #211.
ALPS Advisors first reported a position in GILD in Q3 2013 and has held it in 51 quarters since. The position peaked at $51.5M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- ALPS Advisors held 50,414 shares of Gilead Sciences worth $7.03M as of Q1 2026.
- ALPS Advisors sold 3,697 Gilead Sciences shares in Q1 2026, an estimated $518K.
- Gilead Sciences made up 0.03% of ALPS Advisors's portfolio in Q1 2026, its #211 holding.
- ALPS Advisors first reported a position in Gilead Sciences in Q3 2013 and has held it in 51 quarters since.
- ALPS Advisors's Gilead Sciences position peaked at $51.5M in Q3 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.